0001673772-22-000001.txt : 20220603 0001673772-22-000001.hdr.sgml : 20220603 20220603094626 ACCESSION NUMBER: 0001673772-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220603 DATE AS OF CHANGE: 20220603 EFFECTIVENESS DATE: 20220603 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RAPT Therapeutics, Inc. CENTRAL INDEX KEY: 0001673772 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473313701 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-448024 FILM NUMBER: 22993128 BUSINESS ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 489-9000 MAIL ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: FLX Bio, Inc. DATE OF NAME CHANGE: 20160504 D 1 primary_doc.xml X0708 D LIVE 0001673772 RAPT Therapeutics, Inc. 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA CALIFORNIA 94080 (650) 489-9000 DELAWARE FLX Bio, Inc. Corporation true Brian Wong c/o RAPT Therapeutics, Inc. 561 Eccles Avenue South San Francisco CA CALIFORNIA 94080 Executive Officer Director Mary Ann V. Gray c/o RAPT Therapeutics, Inc. 561 Eccles Avenue South San Francisco CA CALIFORNIA 94080 Director Lori Lyons-Williams c/o RAPT Therapeutics, Inc. 561 Eccles Avenue South San Francisco CA CALIFORNIA 94080 Director William J. Rieflin c/o RAPT Therapeutics, Inc. 561 Eccles Avenue South San Francisco CA CALIFORNIA 94080 Director Rodney Young c/o RAPT Therapeutics, Inc. 561 Eccles Avenue South San Francisco CA CALIFORNIA 94080 Executive Officer Linda Kozick c/o RAPT Therapeutics, Inc. 561 Eccles Avenue South San Francisco CA CALIFORNIA 94080 Director Michael F. Giordano c/o RAPT Therapeutics, Inc. 561 Eccles Avenue South San Francisco CA CALIFORNIA 94080 Director Wendye Robbins c/o RAPT Therapeutics, Inc. 561 Eccles Avenue South San Francisco CA CALIFORNIA 94080 Director Dirk Brockstedt c/o RAPT Therapeutics, Inc. 561 Eccles Avenue South San Francisco CA CALIFORNIA 94080 Executive Officer William Ho c/o RAPT Therapeutics, Inc. 561 Eccles Avenue South San Francisco CA CALIFORNIA 94080 Executive Officer Biotechnology Decline to Disclose 06b false 2022-05-27 false true true false 0 50000000 50000000 0 The total offering amount and the total amount sold include the exercise price, $0.0001 per share, payable on the exercise of the warrants by the investor. false 1 0 0 0 false RAPT Therapeutics, Inc. /s/ Rodney Young Rodney Young Chief Financial Officer 2022-06-02